There’s no ‘best’ vaccine, expert says as Canada OKs AstraZeneca shots

There’s no ‘best’ vaccine, expert says as Canada OKs AstraZeneca shots

By

Twinkle Ghosh

Global News

Posted February 27, 2021 12:30 pm

 
 

Updated February 27, 2021 12:55 pm

1:32
Coronavirus: AstraZeneca vaccine has now been approved in Canada

WATCH ABOVE: The AstraZeneca COVID-19 vaccine has now been approved in Canada.


  • comments

    Leave a comment


  • whatsapp


    Share this item via WhatsApp


  • more

    Share this item


  • more

    Share this item

Smaller font
Descrease article font size
-A

Larger font
Increase article font size
A+


  • Share this item via WhatsApp

    whatsapp


  • Share this item on Pinterest

    pinterest

  • Share this item on LinkedIn

    linkedin


  • Share this item on Reddit

    reddit

  • Copy article link

    Copy link

Vaccines from Moderna, Pfizer-BioNTech and AstraZeneca-Oxford have now been approved in Canada.  While Canadians may not get a choice about which COVID-19 vaccine to take, all three offer protection against severe illness, according to experts.

“All of these vaccines are good,” Dr. Bradly Wouters, executive vice-president of science and research at the University Health Network told Global News Friday.

Read more:
What are the differences between Canada’s approved COVID-19 vaccines? Here’s what we know

Available data shows all these three vaccines have the “ability to impact hospitalization” and offer “protection against severe illness,” he said.

Which vaccine is the best?

There’s no “best vaccine” option.

Whichever vaccine is available first, “it’s going to protect you,” Wouters said.

Story continues below advertisement

Parts of the world are already facing which-is-best challenges. Astrazeneca’s vaccine for instance, was cleared for use in Britain and Europe after data suggested that it was about 70 per cent effective.

Italy’s government recently decided to reserve Pfizer and Moderna shots for the elderly and designate the Astrazeneca vaccine for younger, at-risk workers, sparking protests.

“Right now, it’s not vaccine against vaccine, it’s vaccine against virus,” Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, recently told The Associated Press.

Wouters reiterated a similar notion.

“In a pandemic, you need fast results,” he noted and the “priority is to ensure everyone gets vaccinated” and not “debate over which vaccine is better.”

“Each trial involves different people in different places,” he said, and while many may be making comparisons between vaccines from the results of different Phase 3 trials, “such comparisons are misleading,” he said.

After Pfizer and Moderna, AstraZeneca is the third shot officially authorized in the country.

0:59
Health Canada official explains how AstraZeneca’s COVID-19 vaccine works

Health Canada official explains how AstraZeneca’s COVID-19 vaccine works

The two doses of the Pfizer and Moderna shots were found to be about 95 per cent effective against the virus as compared to the AstraZeneca shots that stand at 62 per cent in preventing symptomatic cases.

Story continues below advertisement

However, Wouters said they will all work “as effectively as possible as long as combined with mask-wearing, handwashing and social distancing.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

“We must continue to follow public health guidelines, being cautious until positive cases, hospitalizations and deaths are significantly reduced nationwide,” he said.

Trending Stories

  • Fixed mortgage rates are on the rise, mortgage brokers warn

  • Winning ticket for $70 million Lotto Max draw purchased in Sudbury region

Following Canada’s approval of AstraZeneca’s COVID-19 vaccine Friday, Procurement Minister Anita Anand cautioned against deliberation over “the sort of good or bad” vaccines.

2:08
Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks

Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks

“If there is a vaccine and it’s been authorized by Health Canada, it means that it’s met standards,” Anand said during a press conference Friday.

AstraZeneca shots may not seem equal to its opponents at first glance but “these vaccines do have a use,” she said.

“We have real-world evidence from Scotland and the U.K. for people that have been dosed that have been over 80, and that has shown a significant drop in hospitalizations, to the tune of 84 per cent,” she said.

Story continues below advertisement

“The idea is to have a suite of vaccines that are available. I think Canada is hungry for vaccines, we’re putting more on the buffet table to be used.”

Standards of efficacy

Speaking of the “standards of effectiveness,” Anand said vaccines “should meet at least 50 per cent.”

“If we compare that to the influenza viruses that we authorize every year, if you look back, for example, just to last year, the effectiveness of the flu vaccine against the most common strain was about 64 per cent, across to the next common strain was about 54 per cent,” she said.

As more information becomes available from real-world use, “the efficacy” of the AstraZeneca vaccine might prove to “be much higher,” Anand added.

Read more:
Canada approves AstraZeneca’s COVID-19 vaccine

Considering all the five vaccines that are currently under review, including the Novavax and Johnson & Johnson shots, Anand emphasized that nobody has died so far from “adverse effects” of these vaccines.

“If you look across all the clinical trials of the tens of thousands of people that were involved, the number of cases of people that died from COVID-19 that got vaccine was zero. The number of people that were hospitalized because their COVID-19 disease was so severe was zero. The number of people that died because of an adverse event or an effect of the vaccine was zero,” she said.

Story continues below advertisement

The idea is “to prevent” serious illness, hospitalizations and “of course prevent death,” Anand said.

Storage and distribution

Compared to the other vaccines, the AstraZeneca shot is also easier to administer.

The vaccine can be stored, transported and handled at normal refrigerated conditions (2 to 8 C/36 to 46 F) for at least six months and administered within existing health-care settings.

2:54
Cold storage of COVID-19 vaccine complicates rollout

Cold storage of COVID-19 vaccine complicates rollout – Dec 8, 2020

The Moderna and Pfizer options, meanwhile, must be stored at subzero temperatures until they’re ready to be used, at -4 F and -94 F, respectively.

This is “something we need to take into account,” Dr. Howard Njoo, Canada’s deputy chief public health officer, said during a press conference Friday.

Story continues below advertisement

He said the onboarding of the AstraZeneca vaccine is “another tool in our toolbox.”

“Following the approval of Health Canada, the efficacy stands at 62 per cent, but we have to look at the entire profile of each vaccine because this vaccine is easier to administer than Pfizer and Moderna, so this is something we need to take into account,” he said.

— With files from The Associated Press


View link »

© 2021 Global News, a division of Corus Entertainment Inc.

Leave a comment

Comments

CoronavirusCoronavirus Vaccinevaccine rolloutcoronavirus vaccine rollout canadaastrazenca vs pfizer vaccineastrazeneca vs modernabest coronavirus vaccinecanada approves astrazenecacanada covis-19 vaccinations

Leave a comment

Comments

More from Global News

  • Canada adds 45 new COVID-19 deaths as P.E.I. introduces ‘circuit breaker’ measures

  • COVID-19 cases are down across Canada, but hospitals aren’t celebrating yet. Here’s why

Advertisement


View link »

Tagged , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *